FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to xenon-sparing combined anaesthesia. At the stage of maintaining anaesthesia during inhalation of xenon with concentration of 40–45% in the gas mixture inhaled by the patient, the flow is set in range of 150–200 ml/min and FiO2 is not lower than 35%, as well as continuous intravenous infusion of the sedative preparation dexmedetomidine in mode of 0.5 mcg/kg/h.
EFFECT: invention allows to optimize consumption of expensive xenon anaesthetic without loss of its positive properties.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPIOID-SPARING COMBINED ANESTHESIA METHOD | 2023 |
|
RU2821771C1 |
| METHOD FOR PREVENTION OF POSTANAESTHESIA AGITATION BY INHALATION OF XENON | 2019 |
|
RU2731797C1 |
| METHOD FOR ANESTHETIC MAINTENANCE DURING RADICAL SURGERY FOR CANCER PATIENTS | 2016 |
|
RU2627289C1 |
| METHOD OF GENERAL ANESTHESIA WITH PRESERVED SPONTANEOUS BREATHING FOR MEDIUM- AND LOW-TRAUMATIC SURGICAL OPERATIONS | 2018 |
|
RU2703686C1 |
| METHOD OF ANAESTHETIC MANAGEMENT OF INTRAOPERATIVE MONITORING OF SPINAL FUNCTION | 2011 |
|
RU2457002C1 |
| METHOD FOR ANESTHESIA AT SURGICAL INTERFERENCES IN ONCOLOGICAL PATIENTS | 2006 |
|
RU2319514C2 |
| METHOD FOR CONTINUOUS ANESTHESIA BY XENON DURING CARDIAC SURGERY OPERATIONS IN CONDITIONS OF ARTIFICIAL CIRCULATION | 2007 |
|
RU2339409C1 |
| METHOD FOR PREVENTION OF EARLY POSTOPERATIVE COGNITIVE DYSFUNCTION IN PATIENTS WITH DIGESTIVE ORGANS PATHOLOGY | 2017 |
|
RU2636867C1 |
| METHOD FOR XENON ANAESTHESIA IN CHILDREN | 2010 |
|
RU2446837C1 |
| METHOD FOR ANAESTHESIA ACCOMPANYING ADENOTOMY AND TONSILLOTOMY IN CHILDREN | 2013 |
|
RU2532015C1 |
